Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Acute × MLN 8237 × Clear all

NCT02560025 2020-05-05

Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML

Phase 2 Completed

42 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute